comparemela.com

Latest Breaking News On - Fat free mass - Page 1 : comparemela.com

"Acceptability, Compliance, and Safety of Non-small Cell Lung Cancer Ca" by Elaine S. Rogers, Rita Sasidharan et al.

Objective: Cancer cachexia is defined as: a ‘multifactorial syndrome’, and it has been suggested that a multitargeted approach is required in its management. High prevalence is seen within non-small cell lung cancer, and patients may continue to experience cachexia post end of anti-cancer treatment, and in the late/end stage. Material and Methods: Participants who had completed week 20/End of Trial visit in the main Auckland’s Cancer Cachexia evaluating Resistance Training (ACCeRT) study were invited to continue with treatment under compassionate use. Participants could continue with 2.09 g of eicosapentaenoic acid (EPA), 300 mg COX-2 inhibitor (celecoxib), once daily; plus two sessions per week of progressive resistance training (PRT), and 20 g oral essential amino acids (EAA); high in leucine, in a split dose over three days post each session. Data was collected on the acceptability, compliance and adherence to medication/PRT sessions. Secondary endpoints included: change in bo

World-health-organization-quality-of-life
Cancer-cachexia
Resistance-training
Functional-assessment
Cachexia-therapy
World-health-organization-quality
Fat-free-mass
Multi-targeted-treatment
Sclc-cachectic-patients
Efractory-cancer-cachexia
Resistance-training

vimarsana © 2020. All Rights Reserved.